| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $312,837,893 ) (Continued on the next page) |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK143569 | Brown adipose tissue derived nidogen-2 as a diabetes therapeutic | 000 | 1 | NIH | 1/26/2026 | $578,846 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA307529 | Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare | 000 | 1 | NIH | 4/17/2026 | $425,088 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DA063124 | A Multiomic Single Nucleus RNA-seq and ATAC-seq Examination of Key Brainstem Respiratory Control Regions from Fentanyl Overdose Decedents with and without Xylazine Present, and Matched Controls | 000 | 1 | NIH | 3/12/2026 | $577,531 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K02DA065836 | Implementation speed and scale-up of personalized tobacco use treatment | 000 | 1 | NIH | 5/7/2026 | $144,372 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AG098547 | Age Differences in the Acquisition and Retention of Flexible Navigation Behaviors | 000 | 1 | NIH | 1/23/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA311209 | Clinical Translation of the First Meitner-Auger PET Theranostic | 000 | 1 | NIH | 5/11/2026 | $641,419 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK144822 | Understanding Phosphatidylserine (PS) as a Signaling Moiety during Differentiation | 000 | 1 | NIH | 5/12/2026 | $610,628 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG095248 | A fiber implant for long-term, deep-brain imaging and manipulation in mouse models of Alzheimer disease | 001 | 1 | NIH | 1/14/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG095248 | A fiber implant for long-term, deep-brain imaging and manipulation in mouse models of Alzheimer disease | 000 | 1 | NIH | 12/30/2025 | $683,028 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM161656 | Mechanosensitive mechanisms regulating cellular coordination during tissue morphogenesis and patterning | 000 | 1 | NIH | 5/18/2026 | $483,175 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K99HD122257 | Study the impact of Bacterial Vaginosis toxins on mouse and human sperm function | 000 | 1 | NIH | 5/19/2026 | $125,142 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21CA307944 | Rational Design of Next-Generation Engineered T Cells for Enhanced Cancer Immunotherapy | 000 | 1 | NIH | 3/30/2026 | $399,829 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI198352 | Targeting VLDLR to prevent both GvHD and leukemia relapse | 000 | 1 | NIH | 5/19/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA298938 | Radiation-guided antibody-drug conjugates for cancer therapy | 000 | 1 | NIH | 3/30/2026 | $542,644 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA305974 | Expand and pull: long-acting IL-7 and oncolytic virus to treat glioblastoma | 000 | 1 | NIH | 5/19/2026 | $645,185 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U01AI195139 | Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients | 000 | 1 | NIH | 3/30/2026 | $919,820 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30CA313986 | Determining the functional epigenomic consequences of HPV viral oncogene expression heterogeneity in oropharyngeal squamous cell carcinoma | 001 | 1 | NIH | 4/16/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163062 | Real-Time Software-Hardware Integration for Dynamic Control of Tissue Mechanical Environments | 000 | 1 | NIH | 3/31/2026 | $1,244,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30CA313986 | Determining the functional epigenomic consequences of HPV viral oncogene expression heterogeneity in oropharyngeal squamous cell carcinoma | 000 | 1 | NIH | 3/30/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K22AG086336 | Identifying and characterizing new therapy targets in TDP-43 proteinopathies | 000 | 1 | NIH | 2/27/2026 | $162,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA248526 | Mechanisms of replication fork protection and recovery | 000 | 7 | NIH | 4/27/2026 | $549,653 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG098482 | Mechanisms of Activity-Dependent Transcription and DNA Repair in Neuronal Longevity | 000 | 1 | NIH | 12/24/2025 | $593,146 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HD120348 | Effects of the ovarian mechanical properties on folliculogenesis | 000 | 1 | NIH | 5/7/2026 | $461,435 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HD120348 | Effects of the ovarian mechanical properties on folliculogenesis | 001 | 1 | NIH | 5/14/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI183261 | Microbial and Host Factors in the Progression to Celiac Disease | 000 | 3 | NIH | 4/28/2026 | $764,474 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163049 | Defining the PS neighborhood proteins on apoptotic cells and their impact on efferocytosis | 000 | 1 | NIH | 2/23/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U01DA064170 | Long term impact of maternal opioid use and management strategies on neurodevelopment in rodent offspring | 000 | 1 | NIH | 4/13/2026 | $733,457 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21HD118485 | Retinoic acid signaling and uterine epithelial cell fate | 000 | 1 | NIH | 5/19/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08DK146198 | Barrestin-mediated desensitization of PTH1R at the intersection of PTH and PTHrP biologic actions | 000 | 1 | NIH | 2/9/2026 | $192,288 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K23NS146687 | Transcriptomic Signatures of Ischemic Stroke: Unlocking Human-Specific Targets for Cerebroprotection | 000 | 1 | NIH | 4/7/2026 | $231,264 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197428 | Viral and host determinants of orthobunyavirus entry. | 000 | 1 | NIH | 5/19/2026 | $37,249 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM162028 | Uncovering the molecular principles of intracellular electrochemistry | 000 | 1 | NIH | 3/24/2026 | $410,520 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197428 | Viral and host determinants of orthobunyavirus entry. | 001 | 1 | NIH | 5/19/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK146938 | Structural and Functional Mechanisms of Podocin in Glomerular Membrane Organization and Kidney Disease | 000 | 1 | NIH | 4/27/2026 | $388,750 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30EY038618 | Elucidating the role of SAMD7 in photoreceptor transcriptional regulation. | 000 | 1 | NIH | 4/21/2026 | $37,249 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA066305 | OPioid use disorder Team structure In emergency Medicine: Associations with short- and Long-term outcomes (OPTIMAL) | 000 | 1 | NIH | 4/21/2026 | $37,312 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA066305 | OPioid use disorder Team structure In emergency Medicine: Associations with short- and Long-term outcomes (OPTIMAL) | 001 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG091773 | Sleep reinforces homeostatic set-points in neural activity and mitigates neurodegenerative disease | 000 | 1 | NIH | 2/6/2026 | $578,856 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21DE034951 | Radiation-guided theranostic agents to monitor response to oral cancer treatment | 000 | 1 | NIH | 2/6/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21EY038491 | Novel Statistical Models for Visual Field Progression in the Ocular Hypertension Treatment Study | 000 | 1 | NIH | 4/3/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30HD118750 | Differentiation of uterine tissue-resident natural killer cells | 002 | 1 | NIH | 4/23/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31NS143355 | Defining the cellular basis of neurological dysfunction in models of ALG8 Congenital Disorder of Glycosylation | 002 | 1 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30HD118750 | Differentiation of uterine tissue-resident natural killer cells | 001 | 1 | NIH | 2/2/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31NS143355 | Defining the cellular basis of neurological dysfunction in models of ALG8 Congenital Disorder of Glycosylation | 000 | 1 | NIH | 2/4/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30HD118750 | Differentiation of uterine tissue-resident natural killer cells | 000 | 1 | NIH | 2/2/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31NS143355 | Defining the cellular basis of neurological dysfunction in models of ALG8 Congenital Disorder of Glycosylation | 001 | 1 | NIH | 2/4/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH136091 | Establishing Specificity and Scalability of Motor Imitation Assessments for Autism Spectrum Disorder | 000 | 1 | NIH | 5/5/2026 | $811,412 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30MH143481 | Investigating the Feasibility of Gene Therapy for the Treatment of TBRS | 001 | 1 | NIH | 2/16/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30MH143481 | Investigating the Feasibility of Gene Therapy for the Treatment of TBRS | 000 | 1 | NIH | 2/16/2026 | $36,673 |
|
